Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan

Figure 3

Associations between physical dysfunction and MSAs in PM/DM patients. The presence of anti-SRP antibodies was more significantly associated with severe physical dysfunction and muscle weakness after treatment. value was less than 0.05. J-HAQ-DI: Japanese version of the Health Assessment Questionnaire Disability Index; ARS: aminoacyl-tRNA synthetase; MDA-5: melanoma differentiation-associated gene 5; SRP: signal recognition particle; MMT: manual muscle test.

(a)

(b)